Current Urology Reports

, 18:82 | Cite as

Prostatic Urethral Lift Versus Transurethral Resection of the Prostate (TURP)

  • Giuseppe Magistro
  • Christian G. Stief
  • Christian Gratzke
Benign Prostatic Hyperplasia (K McVary, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Benign Prostatic Hyperplasia


Lower urinary tract symptoms (LUTS) due to benign prostatic enlargement (BPE) represent one of the most common bothersome conditions impairing quality of life in men. Its management comprises conservative treatment, pharmacotherapy, and various surgical techniques. Medication and surgical procedures provide meaningful relief of LUTS, but their therapeutic efficacy has to be counterbalanced against the associated adverse events and morbidity. With the advent of novel minimally invasive treatment options, the surgical standards are challenged for at least equally effective approaches with a much more favorable safety profile. Clinical randomized controlled trials confirmed that PUL is able to provide rapid and durable relief of LUTS without compromising sexual function. However, in order to define the value and true benefit of a novel technique among established surgical procedures, the direct comparison with the reference method TURP is necessary. This was the main objective of the BPH6 study, which evaluated symptom relief, recovery experience, sexual function, urinary continence, and safety of PUL compared to TURP. Over a 2-year follow-up, no relevant negative impact on erectile function, urinary continence, and treatment-related safety was observed for both procedures. Improvement of LUTS was better after TURP, whereas PUL turned out to be superior in terms of quality of recovery, ejaculatory function, and quality of sleep. PUL can be considered in selected patients with bothersome LUTS, with special interest in the complete preservation of sexual function and a rapid and smooth return to daily activity.


Lower urinary tract symptoms (LUTS) Benign prostatic enlargement (BPE) Benign prostatic hyperplasia (BPH) TURP 


Compliance with Ethical Standards

Conflict of Interest

Giuseppe Magistro, Christian G. Stief, and Christian Gratzke each declare no potential conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


  1. 1.
    Vuichoud C, Loughlin KR. Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol. 2015;22(Suppl 1):1–6.PubMedGoogle Scholar
  2. 2.
    Bosch JL, Bangma CH, Groeneveld FP, Bohnen AM. The long-term relationship between a real change in prostate volume and a significant change in lower urinary tract symptom severity in population-based men: the Krimpen study. Eur Urol. 2008;53(4):819–25. discussion 25-7 CrossRefPubMedGoogle Scholar
  3. 3.
    Bosch JL, Tilling K, Bohnen AM, Bangma CH, Donovan JL. Establishing normal reference ranges for prostate volume change with age in the population-based Krimpen-study: prediction of future prostate volume in individual men. Prostate. 2007;67(16):1816–24.CrossRefPubMedGoogle Scholar
  4. 4.
    Loeb S, Kettermann A, Carter HB, Ferrucci L, Metter EJ, Walsh PC. Prostate volume changes over time: results from the Baltimore Longitudinal Study of Aging. J Urol. 2009;182(4):1458–62.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Parsons JK, Wilt TJ, Wang PY, Barrett-Connor E, Bauer DC, Marshall LM, et al. Progression of lower urinary tract symptoms in older men: a community based study. J Urol. 2010;183(5):1915–20.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Roehrborn CG. BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE. BJU Int. 2008;101(Suppl 3):17–21.CrossRefPubMedGoogle Scholar
  7. 7.
    Taylor BC, Wilt TJ, Fink HA, Lambert LC, Marshall LM, Hoffman AR, et al. Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study. Urology. 2006;68(4):804–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Roehrborn CG. Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). Med Clin North Am. 2011;95(1):87–100.CrossRefPubMedGoogle Scholar
  9. 9.
    Verhamme KM, Dieleman JP, Bleumink GS, Bosch JL, Stricker BH, Sturkenboom MC. Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph project. Eur Urol. 2003;44(5):539–45.CrossRefPubMedGoogle Scholar
  10. 10.
    Roehrborn CG, et al. American Urological Association Guideline: management of benign prostatic hyperplasia (BPH). American Urological Association Education and Research Inc. 2003.Google Scholar
  11. 11.
    McVary KT RC, Avins AL. American Urological Association Guideline: management of Benign Prostatic Hyperplasia (BPH); American Urological Association Education and Research, Inc. 2010.Google Scholar
  12. 12.
    Gravas S, et al. EAU guidelines on the management of non-neurogenic Male Lower Urinary Tract Symptoms (LUTS), including benign prostatic obstruction (BPO) 2017.Google Scholar
  13. 13.
    McNicholas TA. Benign prostatic hyperplasia and new treatment options—a critical appraisal of the UroLift system. Med Devices (Auckl). 2016;9:115–23.CrossRefPubMedCentralGoogle Scholar
  14. 14.
    McNicholas TA, Woo HH, Chin PT, Bolton D, Fernandez Arjona M, Sievert KD, et al. Minimally invasive prostatic urethral lift: surgical technique and multinational experience. Eur Urol. 2013;64(2):292–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Roehrborn CG, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, et al. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. J Urol. 2013;190(6):2161–7.CrossRefPubMedGoogle Scholar
  16. 16.
    McVary KT, Gange SN, Shore ND, Bolton DM, Cowan BE, Brown BT, et al. Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift. J Sex Med. 2014;11(1):279–87.CrossRefPubMedGoogle Scholar
  17. 17.
    Cantwell AL, Bogache WK, Richardson SF, Tutrone RF, Barkin J, Fagelson JE, et al. Multicentre prospective crossover study of the ‘prostatic urethral lift’ for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. BJU Int. 2014;113(4):615–22.CrossRefPubMedGoogle Scholar
  18. 18.
    Chin PT, Bolton DM, Jack G, Rashid P, Thavaseelan J, Yu RJ, et al. Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology. 2012;79(1):5–11.CrossRefPubMedGoogle Scholar
  19. 19.
    Gratzke C, Barber N, Speakman MJ, Berges R, Wetterauer U, Greene D, et al. Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study. BJU Int. 2016;Google Scholar
  20. 20.
    Rukstalis D, Rashid P, Bogache W, Tutrone R, Barkin J, Chin P, et al. Two year durability after crossover to the prostatic urethral lift from randomized. Blinded Sham BJU international. 2016;Google Scholar
  21. 21.
    Shore N, Freedman S, Gange S, Moseley W, Heron S, Tutrone R, et al. Prospective multi-center study elucidating patient experience after prostatic urethral lift. Can J Urol. 2014;21(1):7094–101.PubMedGoogle Scholar
  22. 22.
    Sonksen J, Barber NJ, Speakman MJ, Berges R, Wetterauer U, Greene D, et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol. 2015;68(4):643–52.CrossRefPubMedGoogle Scholar
  23. 23.
    Woo HH, Bolton DM, Laborde E, Jack G, Chin PT, Rashid P, et al. Preservation of sexual function with the prostatic urethral lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Sex Med. 2012;9(2):568–75.CrossRefPubMedGoogle Scholar
  24. 24.
    Woo HH, Chin PT, McNicholas TA, Gill HS, Plante MK, Bruskewitz RC, et al. Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int. 2011;108(1):82–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Perera M, Roberts MJ, Doi SA, Bolton D. Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Urol. 2015;67(4):704–13.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Giuseppe Magistro
    • 1
  • Christian G. Stief
    • 1
  • Christian Gratzke
    • 1
  1. 1.Department of UrologyLudwig-Maximilians-University of MunichMunichGermany

Personalised recommendations